What cardiovascular benefits are due to the drug itself versus the weight loss
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may be a practical, adjunctive treatment option for patients with psoriasis and metabolic comorbidities, according to The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis: A Review, which appears in JAMA Dermatology
Premier : rethinking the protein-to-calorie ratio
For others, it may be sleep quality, hormone balance, thyroid function, insulin resistance, inflammation, or overall metabolic health
If you experience fluid retention, contact your doctor or healthcare provider